Apollo Hospitals
Working at Apollo Hospitals
Company Summary
Overall Rating

5% above

Highly rated for
Job security, Skill development, Company culture
Work Policy




Top Employees Benefits
About Apollo Hospitals

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models. The Group also has Telemedicine facilities across several countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation. In addition, ‘ASK Apollo’ – an online consultation portal and Apollo Home Health provide the care continuum.
The cornerstones of Apollo’s legacy are its unstinting focus on clinical excellence, affordable costs, modern technology and forward-looking research & academics. Apollo Hospitals was among the first few hospitals in the world to leverage technology to facilitate seamless healthcare delivery. The organization embraced the rapid advancement in medical equipments across the world, and pioneered the introduction of several cutting edge innovations in India. Recently, South East Asia’s first Proton Therapy Centre commenced operations at the Apollo Centre in Chennai.
Since its inception, Apollo Hospitals has been honoured by the trust of over 150 million individuals who came from 140 countries. At the core of Apollo’s patient-centric culture is TLC (Tender Loving Care), the magic that inspires hope amongst its patients. As a responsible corporate citizen, Apollo Hospitals takes the spirit of leadership well beyond business and has embraced the responsibility of keeping India healthy. Recognizing that Non Communicable Diseases (NCDs) are the greatest threat to the nation, Apollo Hospitals is continuously educating people about preventive healthcare as the key to wellness.
UR Life
Apollo Shine Foundation
Apollo Hospitals Ratings
Overall Rating
Category Ratings
Job security
Skill development
Company culture
Work-life balance
Work satisfaction
Salary
Promotions
Work Policy at Apollo Hospitals
Apollo Hospitals Reviews
Top mentions in Apollo Hospitals Reviews
Compare Apollo Hospitals with Similar Companies
Change Company | Change Company | Change Company | ||
---|---|---|---|---|
Overall Rating | 4.1/5 based on 4.9k reviews | 4.0/5 based on 2.7k reviews | 4.0/5 based on 2.3k reviews | 4.2/5 based on 1.7k reviews |
Highly Rated for | Skill development Job security Work-life balance | Job security Work-life balance Company culture | Skill development Job security Work-life balance | Job security Skill development Company culture |
Critically Rated for | No critically rated category | Promotions | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 83% employees reported | Hybrid 83% employees reported | Work from office 87% employees reported | Work from office 78% employees reported |
Rating by Women Employees | 4.1 Good rated by 1.8k women | 4.1 Good rated by 757 women | 4.0 Good rated by 846 women | 4.2 Good rated by 298 women |
Rating by Men Employees | 4.1 Good rated by 2.6k men | 4.0 Good rated by 1.8k men | 4.0 Good rated by 1.2k men | 4.2 Good rated by 1.2k men |
Job security | 4.0 Good | 4.1 Good | 3.9 Good | 4.1 Good |
Apollo Hospitals Salaries
Staff Nurse
Pharmacist
Hospital Pharmacist
Clinical Pharmacist
Nursing Staff
Lab Technician
Registered Nurse
Medical Officer
Operations Executive
Supervisor
Apollo Hospitals Interview Questions
Apollo Hospitals Jobs
Apollo Hospitals News
Ethereum Adoption Surges as BlackRock, PayPal, and Fintech Giants Tokenize Billions
- Tokenized AUM on Ethereum has surpassed $5 billion as of June 2025, showing significant growth since early 2025, per Token Terminal data.
- BlackRock leads the surge in tokenized funds on Ethereum, with other major players like PayPal, WisdomTree, Franklin Templeton, Apollo, and Global Dollar Network also contributing.
- Traditional financial institutions are increasingly entering the DeFi space by utilizing Ethereum's smart contracts to launch digital financial products such as tokenized funds, stablecoins, and digital securities.
- The trend started gaining momentum in late 2023, with substantial growth observed throughout 2024 and exponential expansion in 2025.
- The institutional adoption of Ethereum for asset tokenization is a strong endorsement of Ethereum's position as a fundamental blockchain in real-world asset tokenization.
- Analysts predict Ethereum's dominance in DeFi and tokenized markets will continue to strengthen as more established financial firms and fintech companies integrate with the Ethereum platform.

Big Tech's new recruits are skipping out on college, and tech companies are encouraging it
- Big Tech is increasingly turning against college education in favor of gaining practical experience in tech and startups.
- Tech leaders criticize higher education as expensive, inefficient, and ideologically tilted, pushing for skipping college to enter the workforce sooner.
- Companies like Palantir express opposition to traditional college coursework and advocate for alternative paths to career advancement.
- Young individuals eager to work in tech are opting to skip college altogether or taking unconventional paths like gap years.
- In Silicon Valley, the mystery surrounding Arfur Rock, an anonymous account sharing insider information on startups and VCs, has the tech industry intrigued.
- Goldman Sachs interns are advised to maintain a positive attitude, contribute fresh ideas, and leverage networking opportunities to succeed in the competitive financial industry.
- Due to economic uncertainties like inflation and recession fears, many Americans are hesitant to take big financial risks such as changing jobs or investing in properties.
- JPMorgan and Apollo's decision to slow down recruitment of junior bankers for private equity roles signals a potential shift in the finance industry's recruitment practices.
- The broader implications of the pause in private equity recruiting may impact not only young bankers but also the overall financial sector.
- Recent developments in tech and finance industries, along with the changing attitudes toward traditional education, reflect a shifting landscape in career paths and professional development.
ETH price trend data suggests all future dips are for buying
- Rising spot ETH ETF inflows and BlackRock’s accumulation signal strong institutional investor interest, supporting a bullish outlook.
- A dip to $2,100 could be a strategic entry point, bolstered by tokenized AUM surpassing $5 billion and a potential Q4 breakout driven by year-end strategies.
- Ether price saw volatility this week, reaching a 15-week high of $2,879 and later dropping to $2,433.
- ETH is consolidating around $2,600, with a higher-time frame pattern indicating a potential bearish breakdown below $2,100 if sell pressure increases.
- History shows that Q3 performance for Ether has been modest historically, suggesting a possible dip to $2,100-$2,200 range.
- A price near $2,100 is considered a strategic entry point for ETH with rising spot ETF inflows and BlackRock's accumulation.
- Spot ETH ETFs have seen significant inflows, while BlackRock's Ether holdings have grown to 1.51 million ETH ($3.87 billion), indicating institutional interest.
- Data from Token Terminal shows a surge in tokenized assets under management to over $5 billion, with major players like BlackRock and Apollo contributing.
- Institutional buildup and historical Q4 strength may lead to an ETH breakout by the end of 2025.
- This article does not provide investment advice, and readers are advised to conduct their research before making decisions.
Buy, Sell, Or Hold: Aditya Agarwala Recommends Apollo Hospitals, Tech Mahindra
- Aditya Agarwala, Head of Research and Investments at Invest4edu, recommends buying shares of Apollo Hospitals Enterprise Ltd., Tech Mahindra Ltd., and Torrent Pharmaceuticals Ltd. with specific target prices and stop-loss levels.
- For Apollo Hospitals, the target price is Rs 7,550 with a stop-loss at Rs 6,775. It is a leading healthcare provider in India established in 1983.
- Tech Mahindra is advised as a buy with a target price of Rs 1,715 and a stop-loss at Rs 1,610. It is an Indian multinational IT services and consulting company founded in 1986.
- Agarwala also recommends buying Torrent Pharmaceuticals with a target price of Rs 3,360 and a stop-loss at Rs 3,200. It is a prominent Indian pharmaceutical company established in 1959.

Market Experts' LIVE Stock Recommendations: Buy, Sell or Hold Today?
- The Nifty 50 and Sensex dropped at open following global equities loss due to heightened geopolitical concerns after Israel's attack on Iran.
- Invest4edu recommends buying Tech Mahindra with a target price of Rs 1,715 apiece for a 4.3% upside.
- 26 out of 46 analysts suggest a 'buy' rating for Tech Mahindra.
- Invest4edu advises buying Apollo Hospitals with a target price of Rs 7,550 apiece for a 7.9% upside.
- 26 out of 29 analysts maintain a 'buy' rating for Apollo Hospitals.
- Oil refining stocks are in focus as crude prices surged to over a two-month high due to Israel's air strikes on Iran.
- The brent crude August futures contract traded 5.73% higher at $74.62 a barrel.

Stocks To Buy: Apollo Hospitals, Max Healthcare, Tech Mahindra, Torrent Pharma, SRF
- Analysts have recommended buying stocks from healthcare and pharmaceutical segments for Friday's session.
- Apollo Hospitals Enterprise Ltd., Max Healthcare Institute Ltd., Tech Mahindra Ltd., Torrent Pharmaceuticals Ltd., and SRF Ltd. are the stocks with 'buy' recommendations on Friday.
- Key recommendations include 'buy' for Apollo Hospitals with a target price of Rs 7,550, 'buy' for Tech Mahindra with a target price of Rs 1,715, 'buy' for Torrent Pharma with a target price of Rs 3,360, 'buy' for Max Healthcare Institute with a target price of Rs 1,265, and 'buy' for SRF with a target price of Rs 3,190.
- Various analysts provided insights and target prices for these recommended stocks.
- Apollo Hospitals has 26 'buy' ratings out of 29 analysts while Tech Mahindra has 26 'buy' ratings out of 46 analysts.
- Meanwhile, Torrent Pharma has 20 'buy' ratings out of 33 analysts, Max Healthcare Institute has 16 'buy' ratings out of 24 analysts, and SRF has 15 'buy' ratings out of 33 analysts.
- Investors are advised to consult their financial advisors before making investment decisions.
- The views expressed are those of the investment advisers and not of NDTV Profit.
- The article provides insights into the stock recommendations and potential upside as per analysts' views.

Polygon Unveils Plan for Massive TPS Boost & Cross-Chain Liquidity
- Polygon has revealed a new roadmap to enhance blockchain support for payments and real-world assets.
- The plan focuses on increasing throughput, speeding up transaction finality, and attracting institutional players.
- Polygon aims to become a leading layer for global financial activities.
- The Bhilai Upgrade in July 2025 targets a throughput of over 1,000 transactions per second with lower transaction finality and reduced gas fees.
- Polygon plans to achieve over 5,000 TPS and implement the Validator-Elected Block Producer system by late 2025.
- The Gigagas upgrade post-2026 aims for a network capable of handling 100,000 TPS for on-chain payments and RWA transfers.
- Polygon is attracting institutional adoption with major names like Stripe, Reliance Jio, BlackRock, Apollo, and Hamilton Lane already using its network.
- It leads in USDC wallet addresses and ranks third in daily active USDT addresses, demonstrating its growing role in stablecoin transactions.
- Polygon has processed $3.7 billion in peer-to-peer activity in April 2025 and hosts over $271 million in tokenized real-world assets.
- The platform acts as a bridge between traditional finance and Web3 through its efficient infrastructure.

Nifty 50 Top Gainers, Losers On June 12: Asian Paints, Tata Motors To Trent
- On June 12, the NSE Nifty 50 closed 1.01% down at 24,888.2, while the BSE Sensex closed 1% lower at 81,691.98.
- Winners on Thursday included Apollo Hospitals, Dr. Reddy's, Bajaj Finserv, Asian Paints, and Tech Mahindra.
- Losers on the same day were Tata Motors, Shriram Finance, Trent, Titan Co., and Coal India.
- Apollo Hospitals was the biggest gainer, closing 1% higher at Rs 6,996.50, followed by Dr. Reddy's and Bajaj Finserv.
- Tata Motors was the biggest laggard closing 2.86% lower at Rs 715.35, followed by Shriram Finance and Trent.
- The Nifty and Sensex slumped due to the drag from Larsen & Toubro Ltd. and Infosys Ltd., with Nifty ending at 24,888.2 and Sensex closing at 81,691.98.
- Both Nifty and Sensex opened on a muted note, trading in a narrow range, before declining later in the session.
- During the last leg of the trade, Nifty dropped 1.25% to reach 24,825.9, and Sensex decreased by 1.20% to 81,523.16.

Apollo Hospitals Gets Target Price Hike As HSBC Remains Bullish
- HSBC reaffirms 'buy' rating for Apollo Hospitals Enterprise Ltd. and raises the target price by 17% to Rs 8,090 after strong fourth-quarter results.
- Apollo Hospitals reported a 53.5% increase in net profit driven by a 10% year-on-year revenue rise attributed to volume and mix improvements.
- Apollo aims to achieve cost breakeven for its 24x7 platform by the third or fourth quarter of FY26, supported by scale improvement.
- HSBC remains optimistic about Apollo's growth potential, including plans for a new 700-bed facility and steady Ebitda margins projected for FY26-28.

Broker’s call: Apollo Hospitals (Outperform)
- Apollo Hospitals Enterprise’s Q4-FY25 EBITDA marginally missed consensus by 2% but was in line with the estimate.
- Hospitals/HealthCo/AHLL revenue grew 10/17/11% y-o-y with 24.3% EBITDA margin for the hospital segment.
- Ongoing India-Bangladesh tensions impacted patient volumes by 2 percentage points in Q4-FY25.
- Target FY27E EV/EBITDA of 29x assigned to the hospital segment; FY27E EV/EBITDA multiple of 15x assigned to the Apollo HealthCo-Keimed merged entity.
Apollo Hospitals Subsidiaries
Apollo Pharmacy
Apollo Health and Lifestyle Limited
Family Health Plan
Apollo Diagnostics
Medvarsity Online
Apollo Medskills
Apollo Hospitals Offices
Compare Apollo Hospitals with




















Contribute & help others!
Companies Similar to Apollo Hospitals












Apollo Hospitals FAQs
Reviews
Interviews
Salaries
Users